Autogenous Bone: The Gold Standard For Bone Regeneration

Richard J. Miron,Homayoun H. Zadeh,Tobias Fretwurst,Kathia Nelson,Yufeng Zhang,Reinhard Gruber,Michael A. Pikos,Ferdinando D'Avenia
2019-01-01
Abstract:For bone regeneration, there is a great clinical need for bone grafting materials that possess excellent biocompatibility and osteoinductivity without eliciting an antigenic effect. Replacement biomaterials have attempted to mimic autogenous bone grafts, with manufacturers commonly reporting on their osteoconductive, osteoinductive, or osteogenic potential. Of all grafting materials presently available on the market, however, only autogenous bone simultaneously takes advantage of these three properties by totally immunocompatible means. Autografts release a wide array of growth factors and cytokines that regulate the behavior of bone-forming osteoblasts and bone-resorbing osteoclasts. Several factors remain essential to optimize autogenous bone harvesting. Over the past decade, studies have revealed the impact of bone harvesting techniques on the consolidation of autografts. It is now known that certain harvesting techniques improve the viability of cells contained within autografts and further release higher levels of growth factors. This chapter provides the biologic background on bone cells derived from autografts involved in graft consolidation and discusses how harvesting technique is tightly regulated to bone cell viability and subsequent growth factor release. Thereafter, the clinical indications for autogenous bone (either in block or particle form) are presented with various case presentations to support their use. Lastly, a new concept termed bone conditioned media is presented as part of future research toward collecting autogenous bone-inducing growth factors derived from autogenous bone particles.
What problem does this paper attempt to address?